James R. Johnson
Impact in
- Endocrinology top 0.01%
- Escherichia coli research studies
- Enterobacteriaceae and Cronobacter Research
- Vibrio bacteria research studies
- Molecular Medicine top 0.01%
- Antibiotic Resistance in Bacteria
Papers in
- Endocrinology 238
- Escherichia coli research studies 225
- Enterobacteriaceae and Cronobacter Research 40
-
- Antibiotic Resistance in Bacteria 161
- Co-authors
- Thomas A. RussoMichael A. KuskowskiAdam L. StellBrian JohnstonConnie ClabotsTimothy T. O’BryanAbby GajewskiParissa Delavari
- Journals
- Antimicrobial Agents and Chemotherapy (35 papers)Journal of Clinical Microbiology (34 papers)Infection and Immunity (25 papers)The Journal of Infectious Diseases (21 papers)Clinical Infectious Diseases (19 papers)
- Partner nations
- United StatesAustraliaFrance
In The Last Decade
James R. Johnson
409 papers receiving 22.2k citations
Hit Papers
Peers
Comparison fields: 5 of 188
- Endocrinology 13.0k
- Molecular Medicine 11.0k
- Applied Microbiology and Biotechnology 705
- Food Science 4.4k
- Clinical Biochemistry 1.4k
Countries citing papers authored by James R. Johnson
This map shows the geographic impact of James R. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James R. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James R. Johnson more than expected).
Fields of papers citing papers by James R. Johnson
This network shows the impact of papers produced by James R. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James R. Johnson. The network helps show where James R. Johnson may publish in the future.
Co-authors
The 25 scholars most cited alongside James R. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 6 | |
| 3 | 2020 | 45 | |
| 4 | 2018 | 7 | |
| 5 | 2016 | 98 | |
| 6 | 2016 | 117 | |
| 7 | Corticosteroids in Pulmonary Tuberculosis1 | 2015 | 0 |
| 8 | 2015 | 102 | |
| 9 | 2014 | 157 | |
| 10 | 2014 | 12 | |
| 11 | 2011 | 11 | |
| 12 | 2011 | 66 | |
| 13 | 2009 | 231 | |
| 14 | 2007 | 321 | |
| 15 | 2007 | 27 | |
| 16 | 2002 | 21 | |
| 17 | 1998 | 7 | |
| 18 | Associations of Escherichia coli papG adhesin classes with urinary tract infection | 1997 | 4 |
| 19 | 8- to 13-micron spectrophotometry of Comet IRAS-Araki-Alcock | 1984 | 1 |
| 20 | THE NH 3 Spectrum in Saturn's 5μm window. | 1982 | 1 |
About James R. Johnson
James R. Johnson is a scholar working on Endocrinology, Molecular Medicine, Epidemiology, Clinical Biochemistry and Infectious Diseases, having authored 418 papers that have together received 22.9k indexed citations. Recurring topics across this work include Escherichia coli research studies (225 papers), Antibiotic Resistance in Bacteria (161 papers), Urinary Tract Infections Management (122 papers), Salmonella and Campylobacter epidemiology (54 papers), Enterobacteriaceae and Cronobacter Research (40 papers), Clostridium difficile and Clostridium perfringens research (31 papers), Gut microbiota and health (30 papers) and Bacterial Genetics and Biotechnology (26 papers). The work is most often cited by research in Endocrinology (13.0k citations), Molecular Medicine (11.0k citations), Applied Microbiology and Biotechnology (705 citations), Food Science (4.4k citations) and Clinical Biochemistry (1.4k citations). James R. Johnson has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Thomas A. Russo, Michael A. Kuskowski, Adam L. Stell, Brian Johnston, Connie Clabots, Timothy T. O’Bryan, Abby Gajewski, Parissa Delavari, Stephen B. Porter and Ritu Banerjee. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, Infection and Immunity, The Journal of Infectious Diseases and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.